South Carolina General Assembly
117th Session, 2007-2008

Download This Version in Microsoft Word format

Bill 610

Indicates Matter Stricken
Indicates New Matter


(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)

Indicates Matter Stricken

Indicates New Matter

AMENDED

May 22, 2007

S. 610

Introduced by Senator Thomas

S. Printed 5/22/07--H.

Read the first time April 24, 2007.

            

A BILL

TO AMEND SECTION 44-53-360, AS AMENDED, CODE OF LAWS OF SOUTH CAROLINA, 1976, RELATING TO CONTROLLED SUBSTANCES PRESCRIPTIONS, INCLUDING LIMITATIONS ON QUANTITIES PRESCRIBED, SO AS TO PROVIDE THAT PRESCRIPTIONS FOR CONTROLLED SUBSTANCES IN SCHEDULES III THROUGH V MUST NOT EXCEED A NINETY-DAY SUPPLY.

Amend Title To Conform

Be it enacted by the General Assembly of the State of South Carolina:

SECTION    1.    Section 44-53-360(b) of the 1976 Code is amended to read:

"(b)    Except in emergency situations as prescribed by the Department by regulation, and except when distributed to a registrant or dispensed by a practitioner, other than A pharmacist, no may dispense a controlled substance included in Schedule III, or IV, or V shall be dispensed without pursuant to either a written prescription signed by a practitioner, or a facsimile of a written, signed prescription, transmitted by the practitioner or the practitioner's agent to the pharmacy, or pursuant to an oral prescription, reduced promptly to writing and filed by the pharmacist. A prescription transmitted by facsimile must be received at the pharmacy as it was originally transmitted by facsimile and must include the name and address of the practitioner, the phone number for verbal confirmation, the time and date of transmission, and the name of the pharmacy intended to receive the transmission, as well as any other information required by federal or state law. Such prescription, when authorized, may not be refilled more than five times or later than six months after the date of the prescription unless renewed by the practitioner."

SECTION    2.    Section 44-53-360(e) of the 1976 Code, as amended by Act 396 of 2006, is further amended to read:

"(e)    Prescriptions for controlled substances in Schedules Schedule II through IV, inclusive, with the exception of transdermal patches, must not exceed a thirty-one day supply. Prescriptions for Schedule II substances must be dispensed within sixty ninety days of the date of issue, after which time they are void. Prescriptions for controlled substances in Schedule Schedules III through V, inclusive, must not exceed a ninety-day supply."

SECTION    3.    Section 44-53-360(i) of the 1976 Code is amended to read:

"(i)    Excepting a mail order prescription dispensed in compliance with Chapter 43 of Title 40 for which the dispenser requires proper identification of the recipient, a A prescription for a controlled substance in Schedules II through V may not be filled unless the dispenser knows the recipient or requires proper identification the recipient to produce a government issued photo identification, and the dispenser notes the identification source and number on the prescription, or in a readily retrievable log including:

(1)    prescription number;

(2)    date prescription filled;

(3)    number and type of identification;

(4)    initials of person obtaining and recording information."

SECTION    4.    A.        Chapter 117, Title 44 of the 1976 Code is amended by adding:

"Article 3

Electronic Prescription Processing

Section 44-117-310.    As used in this article:

(1)    'Board' means the State Board of Pharmacy.

(2)    'Confidential Information' means information that is personally identifiable and, can be traced back to the patient or prescribing practitioner, that is accessed or maintained by the pharmacist in the patient's records or that is communicated to the patient, as part of patient counseling, which is privileged, and may be released only to:

(a)    the patient or prescriber or, as the patient or prescriber directs;

(b)    those practitioners, other authorized health care professionals, and other pharmacists where, in the pharmacist's professional judgment, such release is necessary to protect the patient's health and well-being; and

(c)    such other persons or governmental agencies authorized by law to receive such confidential information, regardless of whether such information is in the form of paper, preserved on microfilm, or is stored on electronic media.

(3)    'Digital signature' means an electronic signature based upon cryptographic methods of originator authentication and computed by using a set of rules and set of parameters so that the identity of the signer and the integrity of the data can be verified.

(4)    'Electronic signature' means an electronic sound, symbol, or process attached to or logically associated with a record and executed or adopted by a person with the intent to sign the record.

(5)    'Electronic transmission' means transmission of information by electronic means, including computer to computer, computer to facsimile machine, electronic device to computer, e-mail, or the transmission of the exact visual image of a document by way of electronic equipment.

(6)    'Practitioner' means a health care professional licensed in this State who is authorized by law to issue prescription drug orders.

(7)    'Prescription' or 'Prescription drug order' means a lawful order of a practitioner for a drug or device for a specific patient that is communicated to a pharmacist.

(8)    'Routing company' means a business that electronically receives a prescription or any other confidential information from a prescriber and transmits the prescription or confidential information to the pharmacy specified by the patient in accordance with a contract between the routing company and the prescriber or a company that provides computer software for the management of the prescriber's practice.

Section 44-117-320.    (A)    A practitioner may electronically transmit a prescription to a pharmacy if all of these conditions are met:

(1)    A valid practitioner/patient relationship must exist.

(2)    The prescription must identify the transmitter's phone number for verbal confirmation, the time and date of transmission, and the pharmacy intended to receive the transmission and any other information required by federal or state law.

(3)    The prescription must be transmitted by the authorized practitioner or the practitioner's designated agent to the pharmacy of the patient's choice, and the prescription must be received only by a pharmacy, with no intervening person or entity having access to view, read, manipulate, alter, store, or delete the electronic prescription prior to its receipt at the pharmacy.

(4)    The prescription must be transmitted to the pharmacy of the patient's choice. If the pharmacy of the patient's choice is not equipped with the capability to accept an electronic prescription, the practitioner shall provide the patient with a written prescription, telephone an oral prescription, or transmit via facsimile to the pharmacy of the patient's choice.

(5)    The prescription must have the practitioner's electronic or digital signature or key code.

(6)    The prescription must be sent directly from the practitioner's computer or office directly to the receiving pharmacy of the patient's choice. If an electronic prescription is printed out it must possess an original handwritten signature before being delivered to a patient. If a prescription is a hard copy prescription drug order generated from electronic media, a prescribing practitioner's electronic or manual signature must be present. Prescriptions with electronic signatures must be applied to paper that utilizes security features that will ensure the prescription drug order is not subject to any form of copying or alteration.

(B)    An electronically transmitted prescription is deemed the original prescription drug order if it meets the requirements of this article and other applicable laws and regulations.

(C)(1)    Nothing in this section may be construed to prohibit a practitioner from using a routing company to transmit a prescription pursuant to this article; except that a routing company shall provide its tax identification number to the Board of Pharmacy before offering its services in this State.

(2)    A routing company:

(a)    may, for the purpose of verifying an audit conducted of the routing company, store any prescription or other confidential information it receives or transmits pursuant to this article in a form that is secure and ensures the confidentiality of the information in compliance with federal and state privacy law; and

(b)    may not add a provision to, delete a provision from, or otherwise modify a prescription or any other confidential information that it receives or transmits pursuant to this article.

Section 44-117-330.    All electronic equipment for receipt of prescription drug orders communicated by way of electronic transmission must have adequate security and system safeguards and must be maintained so as to ensure patient confidentiality and to ensure against unauthorized access or an intervening person or entity having access to view, read, manipulate, alter, store or delete the electronic prescription prior to its receipt by the pharmacy of the patient's choice. The pharmacist shall exercise professional judgment regarding the accuracy, validity, and authenticity of the prescription drug order consistent with existing federal or state laws and regulations. Once the drug has been dispensed, any alterations in prescription drug order data must be documented, including the identification of the pharmacist responsible for the alteration.

Section 44-117-340.    (A)    All laws and regulations applicable to oral prescription drug orders apply to all computer to computer, computer to facsimile machine, electronic device to computer, e-mail, or the transmission of the exact visual image of a document by way of electronic equipment prescription orders.

(B)    A prescription order transmitted by computer to computer, computer to facsimile machine, electronic device to computer, e-mail, or the transmission of the exact visual image of a document by way of electronic equipment must contain all prescription information required pursuant to Section 40-43-86(E) and federal and state law.

(C)    A practitioner or practitioner's agent shall note any generic substitution instructions on the electronic prescription order transmitted computer to computer, computer to facsimile machine, electronic device to computer or e-mail. Such electronic prescription order may follow the format provided for in Section 40-43-86(H)(3) or any other format that clearly indicates the generic substitution instructions.

(D)    A pharmacist may dispense prescription orders transmitted by computer to computer, computer to facsimile machine, electronic device to computer, e-mail, or the transmission of the exact visual image of a document by way of electronic equipment only when a valid patient/physician relationship exists and the prescription has been signed by the prescribing practitioner and transmitted from the practitioner's office or a long-term care facility in compliance with all sections of this article.

(E)    The original document must be assigned the number of the prescription dispensed, and maintained in the pharmacy records for at least two years.

(F)    The facsimile machine receiving prescription drug orders must be in the prescription department of the pharmacy to protect confidentiality and security.

Section 44-117-350.    (A)    Prescription information and other patient health care information received by a pharmacy must be maintained in a manner that protects the integrity and confidentiality of such information as provided by the State Board of Pharmacy in regulation.

(B)    A pharmacy shall provide a mechanism to prevent the disclosure of any information, confidential or otherwise, about patients that was obtained or collected by a pharmacist or pharmacy incidental to the delivery of pharmaceutical care other than as authorized in regulation.

(C)    The pharmacist-in-charge shall:

(a)    establish and maintain written policies and procedures for maintaining the integrity and confidentiality of prescription information and patient health care information. All employees of the pharmacy with access to this information must be required to comply with the established policies and procedures.

(b)    ensure that the requirements of this section are established and implemented.

Section 44-117-360.    To maintain the confidentiality and integrity of confidential information, the computer system must have adequate security and system safeguards designed to prevent and detect unlawful access, modifications, or manipulation of patient records.

Section 44-117-370.    The board may refuse to issue or renew, or may suspend, revoke, restrict the license or the registration of, or fine any person, routing company, or other entity for each incident that allows the divulging or revealing of confidential information to a person other than a person authorized by this article or any other provision of law or for each incident allowing an intervening person or entity to have access to view, read, manipulate, alter, store, or delete the electronic prescription before it is received by the pharmacy.

Section 44-117-380.    A pharmacist or pharmacy must not provide a computer modem or other similar electronic device to a prescriber, health care facility, or any other third party or provider entity for the purpose of providing an incentive to the practitioner, health care facility, or third party or provider entity that refers patients to a particular pharmacy or department. This does not prohibit a hospital from providing in-house equipment for the use of practitioners and the hospital pharmacy to communicate within the system.

Section 44-117-390.    Entities that offer electronic services for a pharmacist or pharmacy must comply with Section 40-43-86(F) of the South Carolina Pharmacy Practice Act."

B.        Sections 44-117-10 through 44-117-50 of the 1976 Code are designated as Article 1, Chapter 117, Title 44, entitled "Prescription Information Privacy Act".

SECTION    5.    This act takes effect upon approval by the Governor.

----XX----

This web page was last updated on Monday, June 22, 2009 at 3:06 P.M.